The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Research Organisation (CRO) Market Research Report 2025
Synopsis
The global Clinical Research Organisation (CRO) market was valued at US$ 14180 million in 2023 and is anticipated to reach US$ 20520 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global Clinical Research Organization (CRO) market is experiencing rapid growth due to the increasing complexity of clinical trials, rising demand for innovative therapies, and outsourcing trends in the pharmaceutical industry. CROs play a critical role in driving drug development and providing comprehensive services throughout the entire clinical research process. As the healthcare landscape evolves, the market for CROs is expected to expand further, driven by advancements in technology, personalized medicine initiatives, and the globalization of clinical trials.
This report aims to provide a comprehensive presentation of the global market for Clinical Research Organisation (CRO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Research Organisation (CRO).
Report Scope
The Clinical Research Organisation (CRO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Research Organisation (CRO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Research Organisation (CRO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed
Segment by Type
Small molecules
Biologics
Segment by Application
Pharmaceutical Company
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Research Organisation (CRO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Clinical Research Organisation (CRO) market was valued at US$ 14180 million in 2023 and is anticipated to reach US$ 20520 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global Clinical Research Organization (CRO) market is experiencing rapid growth due to the increasing complexity of clinical trials, rising demand for innovative therapies, and outsourcing trends in the pharmaceutical industry. CROs play a critical role in driving drug development and providing comprehensive services throughout the entire clinical research process. As the healthcare landscape evolves, the market for CROs is expected to expand further, driven by advancements in technology, personalized medicine initiatives, and the globalization of clinical trials.
This report aims to provide a comprehensive presentation of the global market for Clinical Research Organisation (CRO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Research Organisation (CRO).
Report Scope
The Clinical Research Organisation (CRO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Research Organisation (CRO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Research Organisation (CRO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed
Segment by Type
Small molecules
Biologics
Segment by Application
Pharmaceutical Company
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Research Organisation (CRO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Research Organisation (CRO) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Clinical Research Organisation (CRO) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Research Organisation (CRO) Market Perspective (2019-2030)
2.2 Clinical Research Organisation (CRO) Growth Trends by Region
2.2.1 Global Clinical Research Organisation (CRO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Research Organisation (CRO) Historic Market Size by Region (2019-2024)
2.2.3 Clinical Research Organisation (CRO) Forecasted Market Size by Region (2025-2030)
2.3 Clinical Research Organisation (CRO) Market Dynamics
2.3.1 Clinical Research Organisation (CRO) Industry Trends
2.3.2 Clinical Research Organisation (CRO) Market Drivers
2.3.3 Clinical Research Organisation (CRO) Market Challenges
2.3.4 Clinical Research Organisation (CRO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Research Organisation (CRO) Players by Revenue
3.1.1 Global Top Clinical Research Organisation (CRO) Players by Revenue (2019-2024)
3.1.2 Global Clinical Research Organisation (CRO) Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Research Organisation (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Research Organisation (CRO) Revenue
3.4 Global Clinical Research Organisation (CRO) Market Concentration Ratio
3.4.1 Global Clinical Research Organisation (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Research Organisation (CRO) Revenue in 2023
3.5 Clinical Research Organisation (CRO) Key Players Head office and Area Served
3.6 Key Players Clinical Research Organisation (CRO) Product Solution and Service
3.7 Date of Enter into Clinical Research Organisation (CRO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Research Organisation (CRO) Breakdown Data by Type
4.1 Global Clinical Research Organisation (CRO) Historic Market Size by Type (2019-2024)
4.2 Global Clinical Research Organisation (CRO) Forecasted Market Size by Type (2025-2030)
5 Clinical Research Organisation (CRO) Breakdown Data by Application
5.1 Global Clinical Research Organisation (CRO) Historic Market Size by Application (2019-2024)
5.2 Global Clinical Research Organisation (CRO) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Research Organisation (CRO) Market Size (2019-2030)
6.2 North America Clinical Research Organisation (CRO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Research Organisation (CRO) Market Size by Country (2019-2024)
6.4 North America Clinical Research Organisation (CRO) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Research Organisation (CRO) Market Size (2019-2030)
7.2 Europe Clinical Research Organisation (CRO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Research Organisation (CRO) Market Size by Country (2019-2024)
7.4 Europe Clinical Research Organisation (CRO) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Research Organisation (CRO) Market Size (2019-2030)
8.2 Asia-Pacific Clinical Research Organisation (CRO) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Research Organisation (CRO) Market Size (2019-2030)
9.2 Latin America Clinical Research Organisation (CRO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Research Organisation (CRO) Market Size by Country (2019-2024)
9.4 Latin America Clinical Research Organisation (CRO) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Research Organisation (CRO) Market Size (2019-2030)
10.2 Middle East & Africa Clinical Research Organisation (CRO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Introduction
11.1.4 Charles River Laboratories Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Clinical Research Organisation (CRO) Introduction
11.2.4 IQVIA Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.2.5 IQVIA Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Detail
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Clinical Research Organisation (CRO) Introduction
11.3.4 LabCorp Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.3.5 LabCorp Recent Development
11.4 Domainex
11.4.1 Domainex Company Detail
11.4.2 Domainex Business Overview
11.4.3 Domainex Clinical Research Organisation (CRO) Introduction
11.4.4 Domainex Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.4.5 Domainex Recent Development
11.5 Evotec AG
11.5.1 Evotec AG Company Detail
11.5.2 Evotec AG Business Overview
11.5.3 Evotec AG Clinical Research Organisation (CRO) Introduction
11.5.4 Evotec AG Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.5.5 Evotec AG Recent Development
11.6 Genscript Biotech
11.6.1 Genscript Biotech Company Detail
11.6.2 Genscript Biotech Business Overview
11.6.3 Genscript Biotech Clinical Research Organisation (CRO) Introduction
11.6.4 Genscript Biotech Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.6.5 Genscript Biotech Recent Development
11.7 GVK Biosciences
11.7.1 GVK Biosciences Company Detail
11.7.2 GVK Biosciences Business Overview
11.7.3 GVK Biosciences Clinical Research Organisation (CRO) Introduction
11.7.4 GVK Biosciences Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.7.5 GVK Biosciences Recent Development
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Detail
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Introduction
11.8.4 Aurobindo Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.8.5 Aurobindo Pharma Recent Development
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Detail
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Introduction
11.9.4 Eurofins Scientific Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.9.5 Eurofins Scientific Recent Development
11.10 Reprocell
11.10.1 Reprocell Company Detail
11.10.2 Reprocell Business Overview
11.10.3 Reprocell Clinical Research Organisation (CRO) Introduction
11.10.4 Reprocell Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.10.5 Reprocell Recent Development
11.11 Dalton Pharma
11.11.1 Dalton Pharma Company Detail
11.11.2 Dalton Pharma Business Overview
11.11.3 Dalton Pharma Clinical Research Organisation (CRO) Introduction
11.11.4 Dalton Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.11.5 Dalton Pharma Recent Development
11.12 NovAliX
11.12.1 NovAliX Company Detail
11.12.2 NovAliX Business Overview
11.12.3 NovAliX Clinical Research Organisation (CRO) Introduction
11.12.4 NovAliX Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.12.5 NovAliX Recent Development
11.13 Jubilant Biosys
11.13.1 Jubilant Biosys Company Detail
11.13.2 Jubilant Biosys Business Overview
11.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Introduction
11.13.4 Jubilant Biosys Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.13.5 Jubilant Biosys Recent Development
11.14 Lupin Pharmaceuticals
11.14.1 Lupin Pharmaceuticals Company Detail
11.14.2 Lupin Pharmaceuticals Business Overview
11.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Introduction
11.14.4 Lupin Pharmaceuticals Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.14.5 Lupin Pharmaceuticals Recent Development
11.15 Piramal Pharma
11.15.1 Piramal Pharma Company Detail
11.15.2 Piramal Pharma Business Overview
11.15.3 Piramal Pharma Clinical Research Organisation (CRO) Introduction
11.15.4 Piramal Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.15.5 Piramal Pharma Recent Development
11.16 Sun Pharmaceutical
11.16.1 Sun Pharmaceutical Company Detail
11.16.2 Sun Pharmaceutical Business Overview
11.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Introduction
11.16.4 Sun Pharmaceutical Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.16.5 Sun Pharmaceutical Recent Development
11.17 Sai Ganga Panakeia
11.17.1 Sai Ganga Panakeia Company Detail
11.17.2 Sai Ganga Panakeia Business Overview
11.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Introduction
11.17.4 Sai Ganga Panakeia Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.17.5 Sai Ganga Panakeia Recent Development
11.18 Vitas Pharma
11.18.1 Vitas Pharma Company Detail
11.18.2 Vitas Pharma Business Overview
11.18.3 Vitas Pharma Clinical Research Organisation (CRO) Introduction
11.18.4 Vitas Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.18.5 Vitas Pharma Recent Development
11.19 Pharmaron Beijing
11.19.1 Pharmaron Beijing Company Detail
11.19.2 Pharmaron Beijing Business Overview
11.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Introduction
11.19.4 Pharmaron Beijing Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.19.5 Pharmaron Beijing Recent Development
11.20 WuXi AppTec
11.20.1 WuXi AppTec Company Detail
11.20.2 WuXi AppTec Business Overview
11.20.3 WuXi AppTec Clinical Research Organisation (CRO) Introduction
11.20.4 WuXi AppTec Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.20.5 WuXi AppTec Recent Development
11.21 Asymchem Laboratories
11.21.1 Asymchem Laboratories Company Detail
11.21.2 Asymchem Laboratories Business Overview
11.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Introduction
11.21.4 Asymchem Laboratories Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.21.5 Asymchem Laboratories Recent Development
11.22 Porton Pharma
11.22.1 Porton Pharma Company Detail
11.22.2 Porton Pharma Business Overview
11.22.3 Porton Pharma Clinical Research Organisation (CRO) Introduction
11.22.4 Porton Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.22.5 Porton Pharma Recent Development
11.23 ChemPartner
11.23.1 ChemPartner Company Detail
11.23.2 ChemPartner Business Overview
11.23.3 ChemPartner Clinical Research Organisation (CRO) Introduction
11.23.4 ChemPartner Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.23.5 ChemPartner Recent Development
11.24 Hangzhou Tigermed
11.24.1 Hangzhou Tigermed Company Detail
11.24.2 Hangzhou Tigermed Business Overview
11.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Introduction
11.24.4 Hangzhou Tigermed Revenue in Clinical Research Organisation (CRO) Business (2019-2024)
11.24.5 Hangzhou Tigermed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Clinical Research Organisation (CRO) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small molecules
Table 3. Key Players of Biologics
Table 4. Global Clinical Research Organisation (CRO) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Clinical Research Organisation (CRO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Clinical Research Organisation (CRO) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Clinical Research Organisation (CRO) Market Share by Region (2019-2024)
Table 8. Global Clinical Research Organisation (CRO) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Clinical Research Organisation (CRO) Market Share by Region (2025-2030)
Table 10. Clinical Research Organisation (CRO) Market Trends
Table 11. Clinical Research Organisation (CRO) Market Drivers
Table 12. Clinical Research Organisation (CRO) Market Challenges
Table 13. Clinical Research Organisation (CRO) Market Restraints
Table 14. Global Clinical Research Organisation (CRO) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Clinical Research Organisation (CRO) Market Share by Players (2019-2024)
Table 16. Global Top Clinical Research Organisation (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Research Organisation (CRO) as of 2023)
Table 17. Ranking of Global Top Clinical Research Organisation (CRO) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Clinical Research Organisation (CRO) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Clinical Research Organisation (CRO) Product Solution and Service
Table 21. Date of Enter into Clinical Research Organisation (CRO) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clinical Research Organisation (CRO) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Clinical Research Organisation (CRO) Revenue Market Share by Type (2019-2024)
Table 25. Global Clinical Research Organisation (CRO) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Clinical Research Organisation (CRO) Revenue Market Share by Type (2025-2030)
Table 27. Global Clinical Research Organisation (CRO) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Clinical Research Organisation (CRO) Revenue Market Share by Application (2019-2024)
Table 29. Global Clinical Research Organisation (CRO) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Clinical Research Organisation (CRO) Revenue Market Share by Application (2025-2030)
Table 31. North America Clinical Research Organisation (CRO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Clinical Research Organisation (CRO) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Clinical Research Organisation (CRO) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Clinical Research Organisation (CRO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Clinical Research Organisation (CRO) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Clinical Research Organisation (CRO) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Clinical Research Organisation (CRO) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Clinical Research Organisation (CRO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Clinical Research Organisation (CRO) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Clinical Research Organisation (CRO) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Clinical Research Organisation (CRO) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Charles River Laboratories Company Detail
Table 47. Charles River Laboratories Business Overview
Table 48. Charles River Laboratories Clinical Research Organisation (CRO) Product
Table 49. Charles River Laboratories Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 50. Charles River Laboratories Recent Development
Table 51. IQVIA Company Detail
Table 52. IQVIA Business Overview
Table 53. IQVIA Clinical Research Organisation (CRO) Product
Table 54. IQVIA Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 55. IQVIA Recent Development
Table 56. LabCorp Company Detail
Table 57. LabCorp Business Overview
Table 58. LabCorp Clinical Research Organisation (CRO) Product
Table 59. LabCorp Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 60. LabCorp Recent Development
Table 61. Domainex Company Detail
Table 62. Domainex Business Overview
Table 63. Domainex Clinical Research Organisation (CRO) Product
Table 64. Domainex Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 65. Domainex Recent Development
Table 66. Evotec AG Company Detail
Table 67. Evotec AG Business Overview
Table 68. Evotec AG Clinical Research Organisation (CRO) Product
Table 69. Evotec AG Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 70. Evotec AG Recent Development
Table 71. Genscript Biotech Company Detail
Table 72. Genscript Biotech Business Overview
Table 73. Genscript Biotech Clinical Research Organisation (CRO) Product
Table 74. Genscript Biotech Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 75. Genscript Biotech Recent Development
Table 76. GVK Biosciences Company Detail
Table 77. GVK Biosciences Business Overview
Table 78. GVK Biosciences Clinical Research Organisation (CRO) Product
Table 79. GVK Biosciences Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 80. GVK Biosciences Recent Development
Table 81. Aurobindo Pharma Company Detail
Table 82. Aurobindo Pharma Business Overview
Table 83. Aurobindo Pharma Clinical Research Organisation (CRO) Product
Table 84. Aurobindo Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 85. Aurobindo Pharma Recent Development
Table 86. Eurofins Scientific Company Detail
Table 87. Eurofins Scientific Business Overview
Table 88. Eurofins Scientific Clinical Research Organisation (CRO) Product
Table 89. Eurofins Scientific Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 90. Eurofins Scientific Recent Development
Table 91. Reprocell Company Detail
Table 92. Reprocell Business Overview
Table 93. Reprocell Clinical Research Organisation (CRO) Product
Table 94. Reprocell Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 95. Reprocell Recent Development
Table 96. Dalton Pharma Company Detail
Table 97. Dalton Pharma Business Overview
Table 98. Dalton Pharma Clinical Research Organisation (CRO) Product
Table 99. Dalton Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 100. Dalton Pharma Recent Development
Table 101. NovAliX Company Detail
Table 102. NovAliX Business Overview
Table 103. NovAliX Clinical Research Organisation (CRO) Product
Table 104. NovAliX Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 105. NovAliX Recent Development
Table 106. Jubilant Biosys Company Detail
Table 107. Jubilant Biosys Business Overview
Table 108. Jubilant Biosys Clinical Research Organisation (CRO) Product
Table 109. Jubilant Biosys Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 110. Jubilant Biosys Recent Development
Table 111. Lupin Pharmaceuticals Company Detail
Table 112. Lupin Pharmaceuticals Business Overview
Table 113. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product
Table 114. Lupin Pharmaceuticals Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 115. Lupin Pharmaceuticals Recent Development
Table 116. Piramal Pharma Company Detail
Table 117. Piramal Pharma Business Overview
Table 118. Piramal Pharma Clinical Research Organisation (CRO) Product
Table 119. Piramal Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 120. Piramal Pharma Recent Development
Table 121. Sun Pharmaceutical Company Detail
Table 122. Sun Pharmaceutical Business Overview
Table 123. Sun Pharmaceutical Clinical Research Organisation (CRO) Product
Table 124. Sun Pharmaceutical Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 125. Sun Pharmaceutical Recent Development
Table 126. Sai Ganga Panakeia Company Detail
Table 127. Sai Ganga Panakeia Business Overview
Table 128. Sai Ganga Panakeia Clinical Research Organisation (CRO) Product
Table 129. Sai Ganga Panakeia Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 130. Sai Ganga Panakeia Recent Development
Table 131. Vitas Pharma Company Detail
Table 132. Vitas Pharma Business Overview
Table 133. Vitas Pharma Clinical Research Organisation (CRO) Product
Table 134. Vitas Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 135. Vitas Pharma Recent Development
Table 136. Pharmaron Beijing Company Detail
Table 137. Pharmaron Beijing Business Overview
Table 138. Pharmaron Beijing Clinical Research Organisation (CRO) Product
Table 139. Pharmaron Beijing Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 140. Pharmaron Beijing Recent Development
Table 141. WuXi AppTec Company Detail
Table 142. WuXi AppTec Business Overview
Table 143. WuXi AppTec Clinical Research Organisation (CRO) Product
Table 144. WuXi AppTec Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 145. WuXi AppTec Recent Development
Table 146. Asymchem Laboratories Company Detail
Table 147. Asymchem Laboratories Business Overview
Table 148. Asymchem Laboratories Clinical Research Organisation (CRO) Product
Table 149. Asymchem Laboratories Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 150. Asymchem Laboratories Recent Development
Table 151. Porton Pharma Company Detail
Table 152. Porton Pharma Business Overview
Table 153. Porton Pharma Clinical Research Organisation (CRO) Product
Table 154. Porton Pharma Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 155. Porton Pharma Recent Development
Table 156. ChemPartner Company Detail
Table 157. ChemPartner Business Overview
Table 158. ChemPartner Clinical Research Organisation (CRO) Product
Table 159. ChemPartner Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 160. ChemPartner Recent Development
Table 161. Hangzhou Tigermed Company Detail
Table 162. Hangzhou Tigermed Business Overview
Table 163. Hangzhou Tigermed Clinical Research Organisation (CRO) Product
Table 164. Hangzhou Tigermed Revenue in Clinical Research Organisation (CRO) Business (2019-2024) & (US$ Million)
Table 165. Hangzhou Tigermed Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Research Organisation (CRO) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Clinical Research Organisation (CRO) Market Share by Type: 2023 VS 2030
Figure 3. Small molecules Features
Figure 4. Biologics Features
Figure 5. Global Clinical Research Organisation (CRO) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Clinical Research Organisation (CRO) Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Company Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Clinical Research Organisation (CRO) Report Years Considered
Figure 11. Global Clinical Research Organisation (CRO) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Clinical Research Organisation (CRO) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Clinical Research Organisation (CRO) Market Share by Region: 2023 VS 2030
Figure 14. Global Clinical Research Organisation (CRO) Market Share by Players in 2023
Figure 15. Global Top Clinical Research Organisation (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Research Organisation (CRO) as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Clinical Research Organisation (CRO) Revenue in 2023
Figure 17. North America Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Clinical Research Organisation (CRO) Market Share by Country (2019-2030)
Figure 19. United States Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Clinical Research Organisation (CRO) Market Share by Country (2019-2030)
Figure 23. Germany Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Clinical Research Organisation (CRO) Market Share by Region (2019-2030)
Figure 31. China Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Clinical Research Organisation (CRO) Market Share by Country (2019-2030)
Figure 39. Mexico Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Clinical Research Organisation (CRO) Market Share by Country (2019-2030)
Figure 43. Turkey Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Clinical Research Organisation (CRO) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Charles River Laboratories Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 46. IQVIA Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 47. LabCorp Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 48. Domainex Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 49. Evotec AG Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 50. Genscript Biotech Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 51. GVK Biosciences Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 52. Aurobindo Pharma Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 53. Eurofins Scientific Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 54. Reprocell Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 55. Dalton Pharma Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 56. NovAliX Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 57. Jubilant Biosys Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 58. Lupin Pharmaceuticals Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 59. Piramal Pharma Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 60. Sun Pharmaceutical Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 61. Sai Ganga Panakeia Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 62. Vitas Pharma Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 63. Pharmaron Beijing Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 64. WuXi AppTec Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 65. Asymchem Laboratories Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 66. Porton Pharma Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 67. ChemPartner Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 68. Hangzhou Tigermed Revenue Growth Rate in Clinical Research Organisation (CRO) Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
